Skip to main content
Premium Trial:

Request an Annual Quote

NimbleGen to Distribute DNAStar's New Gene Expression Software

NEW YORK (GenomeWeb News) — NimbleGen customers will receive a free trial of DNAStar’s latest gene-expression software as part of a new distribution agreement between the companies, DNAStar said today.
 
Under terms of the agreement, NimbleGen customers will be provided with a free trial version of ArrayStar v.2.0 when they receive either their chip data or product from NimbleGen.
 
DNAStar said ArrayStar is the first gene expression analysis software product designed specifically for data files from NimbleGen microarrays.
 
The company said the software enables users to determine gene-expression levels, gene relationships and class discoveries, and it offers visualization capabilities such as heat maps, k-means clustering, and other statistical analysis options.
 
Financial terms of the agreement were not released.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.